Enovis Corporation (LON:0I1B)

Market Cap	955.67M -56.2%
Revenue (ttm)	1.66B +11.6%
Net Income	-1.01B
EPS	-17.88
Shares Out	n/a
PE Ratio	n/a
Forward PE	6.88
Dividend	n/a
Ex-Dividend Date	n/a

Volume	123
Average Volume	390
Open	23.30
Previous Close	22.56
Day's Range	22.53 - 23.30
52-Week Range	21.30 - 44.39
Beta	1.65
RSI	41.88
Earnings Date	Feb 26, 2026

About Enovis

Enovis Corporation operates as a medical technology company focus on developing clinically differentiated solutions in the United States and internationally. It operates through two segments: Prevention and Recovery, and Reconstructive segments. The company’s Prevention and Recovery segment offers orthopedic solutions and recovery sciences including rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators management,...

• Industry: Industrial - Capital Goods
• Sector: Industrials
• Founded: 1995
• Employees: 7,367
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0I1B

Financial Performance

In 2024, Enovis's revenue was $2.11 billion, an increase of 23.46% compared to the previous year's $1.71 billion. Losses were -$825.49 million, 2381.9% more than in 2023.

Financial numbers in USD